Loading…
Loading…

| 6586.TWO | CHO Pharma, Inc. | NT$111.50 | NT$23.9B |
| 6891.TWO | Locus Cell Co., Ltd. | NT$43.00 | NT$8.6B |
| 4142.TW | Adimmune Corporation | NT$18.00 | NT$7.6B |
| 4167.TWO | Savior Lifetec Corp. | NT$20.25 | NT$6.7B |
| 1734.TW | Sinphar Pharmaceutical Co. Ltd. | NT$32.50 | NT$6.6B |
| 4157.TWO | TaiGen Biopharmaceuticals Holdings Limited | NT$9.10 | NT$6.5B |
| 4726.TWO | Mycenax Biotech Inc. | NT$24.50 | NT$5.1B |
| 1760.TW | Panion & Bf Biotech Inc. | NT$58.40 | NT$5.0B |
| 4174.TWO | OBI Pharma, Inc. | NT$26.70 | NT$3.5B |
| 6733.TWO | BioGend Therapeutics Co., Ltd. | NT$26.15 | NT$3.5B |